{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.93","value":"14.67"},{"groupId":"OG001","spread":"1.5","value":"3.25"}]}],"title":"ESR, Genistein cycles"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.29","value":"20.00"},{"groupId":"OG001","spread":"0.58","value":"2.50"}]}],"title":"ESR, Placebo cycles"}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Genistein daily throughout chemotherapy cycles 1 and 2, and placebo daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG000","title":"Arm A: Genistein Followed by Placebo"},{"description":"Placebo daily throughout chemotherapy cycles 1 and 2, and genistein daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG001","title":"Arm B: Placebo Followed by Genistein"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Once before treatment starts and then four more times while the study drug is being taken, an 8 - 16 week period if there are no chemotherapy delays","title":"Serum Marker Levels of Inflammation Erythrocyte Sedimentation Rate (ESR; mm/hr) During Cycles of Chemotherapy","type":"SECONDARY","unitOfMeasure":"mm/hr"}